Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology

In this interview, Dr Reinhart Speeckaert emphasizes the importance and reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in dermatology. He also addresses the inappropriate generalization of previously reported MIDs for patient populations with different disease characteristics and shares the steps that can be used to avoid this pitfall. 

Reinhart Speeckaert, MD, PhD, is a dermatology professor in the department of dermatology at Ghent University Hospital in Ghent, Belgium. His clinical work focuses on inflammatory skin disorders, particularly vitiligo, but also on a wide range of other immune-mediated diseases. Dr Speeckaert's first PhD in dermatology focused on the immunosurveillance of melanocytes in conditions ranging from melanoma to vitiligo. His second PhD was in clinical chemistry, and it dealt with the clinical implications of the genetic polymorphism in the haptoglobin gene.

You can read his interview here.